Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.

Baselga J, GГіmez P, Greil R, Braga S, Climent MA, Wardley AM, Kaufman B, Stemmer SM, PГЄgo A, Chan A, Goeminne JC, Graas MP, Kennedy MJ, Ciruelos Gil EM, Schneeweiss A, Zubel A, Groos J, MelezГ­nkovГЎ H, Awada A. J Clin Oncol. 2013 Jul 10,31(20):2586-92. doi: 10.1200/JCO.2012.46.2408. Epub 2013 Jun 3.

Circulating tumor DNA to monitor metastatic breast cancer.

Weiss L, Hufnagl C, Greil R. N Engl J Med. 2013 Jul 4,369(1):93. doi: 10.1056/NEJMc1306040#SA2.

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.

Kubicka S, Greil R, AndrГ© T, Bennouna J, Sastre J, Van Cutsem E, von Moos R, Osterlund P, Reyes-Rivera I, MГјller T, Makrutzki M, Arnold D Ann Oncol. 2013 Sep,24(9):2342-9. doi: 10.1093/annonc/mdt231. Epub 2013 Jul 12.

Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.

Crown JP, DiГ©ras V, Staroslawska E, Yardley DA, Bachelot T, Davidson N, Wildiers H, Fasching PA, Capitain O, Ramos M, Greil R, Cognetti F, Fountzilas G, Blasinska-Morawiec M, Liedtke C, Kreienberg R, Miller WH Jr, Tassell V, Huang X, Paolini J, Kern KA, Romieu G. J Clin Oncol. 2013 Aug 10,31(23):2870-8. doi: 10.1200/JCO.2012.43.3391. Epub 2013 Jul 15.

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.

Gnant M, Pfeiler G, Stöger H, Mlineritsch B, Fitzal F, Balic M, Kwasny W, Seifert M, Stierer M, Dubsky P, Greil R, Steger G, Samonigg H, Fesl C, Jakesz R. Br J Cancer. 2013 Aug 6,109(3):589-96. doi: 10.1038/bjc.2013.367. Epub 2013 Jul 18.

The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma.

Stenner-Liewen F, GrГјnwald V, Greil R, Porta C. Expert Rev Anticancer Ther. 2013 Sep,13(9):1021-33. doi: 10.1586/14737140.2013.833684. Epub 2013 Sep 12.

Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present and future.

Gampenrieder SP, Rinnerthaler G, Greil R. J Oncol. 2013,2013:732047. doi: 10.1155/2013/732047. Epub 2013 Aug 20.

[Successful cancer therapy: chance and challenges].

Greil R, Hiddemann W. Dtsch Med Wochenschr. 2013 Oct,138(41):2083. doi: 10.1055/s-0033-1349623. Epub 2013 Oct 1.

[71-year old woman with neutropenic fever during chemotherapy].

Schlick K, Datz L, Hohla F, Greil R, Hopfinger G. Dtsch Med Wochenschr. 2013 Oct,138(41):2091-2. doi: 10.1055/s-0033-1349528. Epub 2013 Oct 1.

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.

Dubsky P, Brase JC, Jakesz R, Rudas M, Singer CF, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann MC, Petry C, Weber KE, Fisch K, Kronenwett R, Gnant M, Filipits M Br J Cancer. 2013 Dec 10,109(12):2959-64. doi: 10.1038/bjc.2013.671. Epub 2013 Oct 24.